M.H. Cullen

Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party.

G. Read, Sally Stenning, M.H. Cullen et al. · Journal of Clinical Oncology · 1992 · 424 citations

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.

A. Horwich, D.Th. Sleijfer, Sophie D. Fosså et al. · Journal of Clinical Oncology · 1997 · 331 citations

Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report.

M.H. Cullen, Sally Stenning, M C Parkinson et al. · Journal of Clinical Oncology · 1996 · 318 citations

Long-term toxicity of chemotherapy for testicular cancer – the cost of cure

NSA Stuart, C.M. Woodroffe, Richard G. Grundy et al. · British Journal of Cancer · 1990 · 97 citations · Full text

Urology, Testicular Cancer, Medicine +8

Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphoma

Andrew G. Polson, Marna Williams, Aimee Gray et al. · Leukemia · 2010 · 88 citations

Lymphoid Neoplasia, Medicine, Antibody-drug Conjugate +8